https://www.gosh.nhs.uk/news/novel-coronavirus-covid-19-latest-information/
Novel Coronavirus (COVID-19) – latest information
27 Feb 2020, 4 p.m.
Please find below the latest information for patients from NHS England on coronavirus (COVID-19).
The NHS in London and Public Health England (PHE) are well prepared for outbreaks of new infectious diseases. The NHS has put in place measures to ensure the safety of all patients and NHS staff while also ensuring services are available to the public as normal.
The risk to the general public is moderate. If you have arrived back to the UK from mainland China, Thailand, Japan, Republic of Korea, Hong Kong, Taiwan, Singapore, Malaysia, Macau, Iran, northern Italy or South Korea within 14 days, follow the specific advice for returning travellers.
Call 111 now if you've been:
- to Wuhan or Hubei Province in China in the last 14 days (even if you do not have symptoms)
- to Iran and returned to the UK since February 19 (even if you do not have symptoms)
- specific lockdown areas in northern Italy as designated by the Government of Italy and returned to the UK since February 19 (even if you do not have symptoms)
- ‘special care zones’ in South Korea as designated by the Government of the Republic of South Korea and returned to the UK since February 19 (even if you do not have symptoms)
- to other parts of China, including Macau and Hong Kong, in the last 14 days and have a cough, high temperature or shortness of breath (even if it's mild)
- to Thailand, Japan, Taiwan, Singapore, Republic of Korea or Malaysia in the last 14 days and have a cough, high temperature or shortness of breath (even if it's mild)
- to northern Italy (anywhere north of Pisa, Florence and Rimini), Vietnam, Cambodia, Laos or Myanmar and have returned to the UK since February 19 (even if it’s mild)
- in close contact with someone with confirmed coronavirus
Further information is available on gov.uk/coronavirus and nhs.uk.
Like the common cold, coronavirus infection usually occurs through close contact with a person with novel coronavirus via cough and sneezes or hand contact. A person can also be infected by touching contaminated surfaces if they do not wash their hands.
The risk of being in close contact with a person with coronavirus or contaminated surfaces is very low at the current time, as members of the public who have visited Wuhan, Hubei province, China are currently in isolation.
Testing of suspected coronavirus cases is carried out in line with strict regulations. This means that suspected cases are kept in isolation, away from public areas of the hospital and returned home also in isolation. Any equipment that come into contact with suspected cases are thoroughly cleaned as appropriate. Specific guidance has also been shared with NHS staff to help safeguard them and others. Patients can be reassured that their safety is a top priority, and are encouraged to attend all appointments as usual.
Everyone is being reminded to follow Public Health England advice to:
- Always carry tissues with you and use them to catch your cough or sneeze. Then bin the tissue, and wash your hands, or use a sanitiser gel.
- Wash your hands often with soap and water, especially after using public transport. Use a sanitiser gel if soap and water are not available.
- Avoid touching your eyes, nose and mouth with unwashed hands.
- Avoid close contact with people who are unwell.
Could adapting our sinks combat super bugs?
Discover how a Consultant Microbiologist at GOSH turned an innovative idea into a patented product that could revolutionise infection control in hospitals, schools, and airports – helping to stop superbugs like MRSA.
GOSH pilots AI tool to give clinicians more quality-time with patients
Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.
New hope to prevent blindness in children with rare genetic disease
A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).